TipHub

₹10.22

▲ +0.04 +0.39%

As of 29 Jul 2026 · delayed

NSE Listed · Pharmaceuticals

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-05-08
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-14

Nectar Lifesciences Ltd. (NECLIFE)

Volume: 1,02,074Avg Vol 1W: 78,300Avg Vol 1M: 95,29752W Range:₹9.3₹22.4
NSE BSE www.neclife.com AI Report
Key Ratios
Checked just now
Market Cap₹199 Cr
Current Price₹10.22
Previous Close₹10.18
High / Low (52w)₹22.4 / ₹9.3
Volume1,02,074
Avg Vol (1W)78,300
Avg Vol (1M)95,297
Stock P/E—
Book Value₹29.97
Dividend Yield0%
ROE-9.85%
ROA-47.12%
Revenue (TTM)—
Revenue Growth-0.84%
Profit Margin-4,762.44%
Total Debt₹60 Cr
Shares Outstanding19 Cr
Face Value₹1
EPS (TTM)₹0
P/B0.34
Debt / Equity0
50 DMA₹11.49
200 DMA₹13.72
Day change+0.39%
SurveillanceESM · ESM 1
Price Chart
₹10.22▼ 38.51% · 1Y
₹29₹95.3Cr
2025-07-30
2026-07-29

20-day avg volume: 98K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹359 Cr₹6 Cr₹0 Cr₹0 Cr₹5 Cr₹1 Cr₹0 Cr₹1 Cr
EBITDA₹25 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-1 Cr₹-51 Cr
Net Profit₹3 Cr₹6 Cr₹8 Cr₹-130 Cr₹-63 Cr₹-176 Cr₹14 Cr₹-68 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹6 Cr₹0 Cr₹0 Cr₹1,675 Cr₹5 Cr₹1 Cr₹0 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹-87 Cr₹-1 Cr₹0 Cr₹-1 Cr₹-51 Cr
Net Profit₹6 Cr₹8 Cr₹-130 Cr₹-114 Cr₹-63 Cr₹-176 Cr₹14 Cr₹-68 Cr
EPS———-5.07————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2,724 Cr₹2,705 Cr₹2,633 Cr₹2,471 Cr₹2,391 Cr₹2,189 Cr₹2,191 Cr₹2,047 Cr
Total Liabilities₹1,665 Cr₹1,600 Cr₹1,497 Cr₹1,409 Cr₹1,303 Cr₹1,125 Cr₹1,122 Cr₹1,091 Cr
Equity₹1,059 Cr₹1,105 Cr₹1,136 Cr₹1,062 Cr₹1,088 Cr₹1,065 Cr₹1,069 Cr₹956 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹78 Cr₹253 Cr₹294 Cr₹25 Cr₹95 Cr₹134 Cr₹225 Cr₹169 Cr
Investing₹-29 Cr₹-26 Cr₹-33 Cr₹-29 Cr₹17 Cr₹52 Cr₹-17 Cr₹-42 Cr
Financing₹-40 Cr₹-201 Cr₹-252 Cr₹11 Cr₹-119 Cr₹-186 Cr₹-205 Cr₹-128 Cr
Free Cash Flow₹78 Cr₹253 Cr₹294 Cr₹25 Cr₹95 Cr₹134 Cr₹225 Cr₹169 Cr
Shareholding
Promoter 51.84% Institutions 4.24% Public 43.91%
Efficiency & Working Capital
ROCE-8.7%
Interest Coverage-1.2
Dividend Payout—
Debtor Days66 d
Inventory Days132 d
Payable Days84 d
Cash Conversion Cycle114 d
Working Capital Days198 d
Shareholding Details

As of 2026-06-30

Promoter51.8%
FII0.5%
DII3.7%
Institutions4.2%
Public43.9%
Promoter Pledge0%
No. of Shareholders73,834
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Jan 2026Jan 2026Mar 2026Jun 2026
Promoters55.8%55.8%55.8%44.5%44.5%44.5%44.9%44.9%51.8%51.8%51.8%51.8%
FIIs17%16.6%3.2%0.7%1.6%0.8%0.6%0.5%0.6%0.6%0.6%0.5%
DIIs0%0%0%0%0.2%0.2%0.1%5.8%3.5%3.5%4%3.7%
Public27.2%27.6%41%54.7%53.7%54.5%54.4%48.7%44%44%43.5%43.9%
Promoter Pledge100%100%100%99.6%99.6%99.6%98.8%0%0%0%0%0%
No. of Shareholders59,94658,23066,74169,48269,24171,97776,47078,12476,64876,64874,83473,834
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sanjiv GoyalShareholding of Promoter and Promoter Group24.6%4.78 Cr
Sanjiv (huf) - Karta Sanjiv GoyalShareholding of Promoter and Promoter Group22.5%4.36 Cr
Raman GoyalShareholding of Promoter and Promoter Group4.8%92,38,448
Rajasthan Global Securities Private LimitedPublic Shareholding3.7%72,47,763
Nectar Organics Private LimitedShareholding of Promoter and Promoter Group0%0
Orient Alloys Private LimitedShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sanjiv GoyalChairman & Managing Director2025
Rupinder TewariIndependent Non Exe. Director2025
Kuldip Kumar BhasinIndependent Non Exe. Director2025
Indu Pal KaurIndependent Non Exe. Director2025
Surulichamy SenthilkumarExecutive Director2025
Sanjaymohan Singh RawatCompany Sec. & Compli. Officer2025
Sushil KapoorWTD & Director (Finance)2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals Products₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹1,172 Cr61.4%
Outside India₹737 Cr38.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1352222
Corporate Actions
TypeDateValueRemark
buyback2026-01-06₹27 max—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000606
2025000000
2025000101
Insider / Designated-Person Trades

5 recent disclosure(s)

Raman GoyalAcquisition · 80,00,000
Sanjiv GoyalDisposal · 80,00,000
SBICAP Trustee Company LimitedRevoke · 9,94,68,000
SanjivHUFRevoke · 4,36,22,400
Sanjiv GoyalRevoke · 5,58,45,600
Substantial Acquisitions (SAST)

3 disclosure(s)

Buy Back20/01/2026 · —
Market12/12/2025 · 3,62,422
Release Of Pledge30/10/2025 · —
Company Information
Incorporated1995
ChairmanSanjiv Goyal
AuditorDeepak Jindal & Co
Investor Email[email protected]
🌐 www.neclife.com ↗

📍 Village Saidpura, Tehsil Derabassi S A S Nagar, Mohali, Punjab, 140507

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

NDR INVIT RESET 2031NDR Auto Components Ltd.NDR InvIT TrustNew Delhi Television Ltd.Neelamalai Agro Industries Ltd.North Eastern Carrying Corporation Ltd.Neelam Linens and Garments (India) Ltd.Nelcast LimitedNELCO Ltd.Neochem Bio Solutions Ltd.Neogen Chemicals LimitedNephro Care India LimitedAll “N” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search